Literature DB >> 16311353

Maspin expression in carcinoma ex pleomorphic adenoma.

M T Martins1, A Altemani, L Freitas, V C Araújo.   

Abstract

AIMS: To investigate the presence and distribution of the protein maspin in carcinoma ex pleomorphic adenoma (CXPA).
METHODS: Maspin expression was studied by means of immunohistochemistry in 16 cases of CXPA, using the labelled polymer method.
RESULTS: According to the extent of invasion, the tumours were subdivided into: intracapsular (five cases), minimally invasive (four cases), and invasive (seven cases). Twelve patients had carcinoma with only epithelial differentiation, whereas four had a malignant myoepithelial component. Non-luminal cells in the duct-like structures of the remnant pleomorphic adenoma were strongly positive for maspin, whereas only a few luminal cells were immunopositive. A few positive cells were seen in the frequent hypocellular and hyalinised areas. Maspin was abundantly expressed, mainly in non-luminal cells, in transitional areas of CXPA with only epithelial differentiation. In frankly carcinomatous areas there was a gradual decrease in maspin expression. Almost all cells were maspin positive in CXPA with a myoepithelial component. When present, luminal cells were in general negative for maspin.
CONCLUSIONS: When only epithelial cells undergo malignant transformation, maspin expression is gradually lost. In cases with a myoepithelial component, maspin expression is high, and this might be related to the tumour suppressor activity attributed to this cell.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311353      PMCID: PMC1770799          DOI: 10.1136/jcp.2004.025205

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

1.  Maspin is expressed in the nuclei of breast myoepithelial cells.

Authors:  Jorge S Reis-Filho; Fernanda Milanezi; Fernando C Schmitt
Journal:  J Pathol       Date:  2002-06       Impact factor: 7.996

2.  Immunohistochemical detection of maspin is a useful adjunct in distinguishing radial sclerosing lesion from tubular carcinoma of the breast.

Authors:  S M Lele; K Graves; Z Gatalica
Journal:  Appl Immunohistochem Mol Morphol       Date:  2000-03

3.  Malignancy in pleomorphic adenoma. A clinical and microspectrophotometric study.

Authors:  C M Eneroth; A Zetterberg
Journal:  Acta Otolaryngol       Date:  1974-06       Impact factor: 1.494

4.  Maspin expression in myoepithelial tumors of the breast.

Authors:  J S Reis-Filho; F Milanezi; P Silva; F C Schmitt
Journal:  Pathol Res Pract       Date:  2001       Impact factor: 3.250

5.  Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues.

Authors:  T Hojo; Y Akiyama; K Nagasaki; K Maruyama; K Kikuchi; T Ikeda; M Kitajima; K Yamaguchi
Journal:  Cancer Lett       Date:  2001-09-28       Impact factor: 8.679

6.  Carcinoma ex pleomorphic adenoma: a clinicopathologic review.

Authors:  K D Olsen; J E Lewis
Journal:  Head Neck       Date:  2001-09       Impact factor: 3.147

7.  Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast.

Authors:  N Maass; M Teffner; F Rösel; R Pawaresch; W Jonat; K Nagasaki; P Rudolph
Journal:  J Pathol       Date:  2001-10       Impact factor: 7.996

8.  Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression.

Authors:  A Altemani; M T Martins; L Freitas; F Soares; N S Araújo; V C Araújo
Journal:  Histopathology       Date:  2005-06       Impact factor: 5.087

9.  Maspin expression in normal and neoplastic salivary gland.

Authors:  Ricardo de Lima Navarro; Marília Trierveiler Martins; Vera Cavalcanti de Araújo
Journal:  J Oral Pathol Med       Date:  2004-08       Impact factor: 4.253

10.  Maspin expression in invasive breast cancer: association with other prognostic factors.

Authors:  Syed K Mohsin; Ming Zhang; Gary M Clark; D Craig Allred
Journal:  J Pathol       Date:  2003-04       Impact factor: 7.996

View more
  5 in total

Review 1.  Myoepithelial Cells (MEC) of the Salivary Glands in Health and Tumours.

Authors:  Ravi Teja Chitturi; V Veeravarmal; R Madhavan Nirmal; B Venkat Ramana Reddy
Journal:  J Clin Diagn Res       Date:  2015-03-01

2.  Desmoplasia in different degrees of invasion of carcinoma ex-pleomorphic adenoma.

Authors:  Vera Cavalcanti de Araújo; Cristiane Furuse; Patricia Ramos Cury; Albina Altemani; Venâncio Avancini Ferreira Alves; Ney Soares de Araújo
Journal:  Head Neck Pathol       Date:  2007-11-27

Review 3.  Maspin as a tumour suppressor in salivary gland tumour.

Authors:  Bassel Tarakji; Nipun Ashok; Mohammad Kinan Sheirawan; Mohammed Alsakran Altamimi; Faris Alenzi; Saleh Nasser Azzeghaiby; Kusai Baroudi; Mohammad Zakaria Nassani
Journal:  J Clin Diagn Res       Date:  2014-12-05

4.  [Prognostic value of immunohistochemistry in salivary gland cancer].

Authors:  T Ettl; S Schwarz; T Kühnel; P Stockmann; T E Reichert; O Driemel
Journal:  HNO       Date:  2008-02       Impact factor: 1.284

5.  Comparative Analysis of P63, Maspin and Matrix Metalloproteinase 2 Expression in Mucoepidermoid Carcinoma and Adenoid Cystic Carcinoma of Salivary Glands.

Authors:  Nasim Taghavi; Farzad Yazdani; Alireza Akbarzadeh Baghban; Soudabeh Sargolzaei; Parisa Kardouni Khoozestani
Journal:  J Dent (Shiraz)       Date:  2020-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.